1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Chronic Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henschke, N; Koes, BW; Kuijpers, T; Ostelo, R; Rubinstein, SM; van Middelkoop, M; van Tulder, MW; Verhagen, A | 1 |
DworczyĆski, W; Krauze, W; Sarnecka, D; Wysocki, S | 1 |
Halliday, WR | 1 |
1 review(s) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Chronic Disease
Article | Year |
---|---|
Injection therapy and denervation procedures for chronic low-back pain: a systematic review.
Topics: Adrenal Cortex Hormones; Anesthetics, Local; Chronic Disease; Chymopapain; Denervation; Humans; Injections, Epidural; Injections, Intra-Articular; Injections, Intramuscular; Low Back Pain; Randomized Controlled Trials as Topic | 2010 |
2 other study(ies) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Chronic Disease
Article | Year |
---|---|
[Lekopain in the treatment of chronic osteomyelitis (preliminary report)].
Topics: Chronic Disease; Chymopapain; Drug Combinations; Endopeptidases; Humans; Male; Middle Aged; Osteomyelitis; Papain; Staphylococcal Infections | 1984 |
Chymopapain and chemonucleolysis.
Topics: Back Pain; Chronic Disease; Chymopapain; Endopeptidases; Humans; United States; United States Food and Drug Administration | 1978 |